VENTO, Antonio
 Distribuzione geografica
Continente #
EU - Europa 1.798
NA - Nord America 1.305
AS - Asia 801
SA - Sud America 245
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.170
Nazione #
US - Stati Uniti d'America 1.275
RU - Federazione Russa 1.020
SG - Singapore 342
BR - Brasile 199
CN - Cina 185
IE - Irlanda 182
SE - Svezia 173
IT - Italia 125
DE - Germania 80
HK - Hong Kong 77
VN - Vietnam 60
PL - Polonia 52
FR - Francia 49
IN - India 38
FI - Finlandia 28
GB - Regno Unito 28
JP - Giappone 19
AR - Argentina 16
CA - Canada 13
BD - Bangladesh 12
IQ - Iraq 11
ES - Italia 10
BE - Belgio 9
LT - Lituania 9
AT - Austria 8
MX - Messico 8
NL - Olanda 8
UZ - Uzbekistan 8
EC - Ecuador 7
PE - Perù 7
VE - Venezuela 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
TR - Turchia 6
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
UA - Ucraina 4
CL - Cile 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CO - Colombia 2
JM - Giamaica 2
KW - Kuwait 2
OM - Oman 2
SN - Senegal 2
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.170
Città #
Moscow 274
Ashburn 267
Chandler 205
Singapore 195
Dublin 180
San Jose 124
Nyköping 120
Hong Kong 76
Dallas 74
Beijing 54
The Dalles 51
Warsaw 49
Messina 48
Los Angeles 34
Munich 34
Princeton 33
Medford 24
Bremen 23
Ho Chi Minh City 22
São Paulo 21
Des Moines 20
Lauterbourg 18
Frankfurt am Main 14
Helsinki 14
Turku 14
Dearborn 13
Orem 13
Ann Arbor 12
Hyderabad 12
Buffalo 11
Jinan 11
Rome 11
Hanoi 10
Kameido 10
Mumbai 10
Redondo Beach 10
Tianjin 10
Brussels 9
Jacksonville 9
Tokyo 9
Atlanta 8
Nanjing 8
New York 8
Boardman 7
Nuremberg 7
Seattle 7
Stockholm 7
Tashkent 7
Amsterdam 6
Denver 6
Dong Ket 6
Hangzhou 6
Santa Clara 6
West Jordan 6
Bexley 5
Chicago 5
Porto Alegre 5
Quito 5
Baghdad 4
Baku 4
Blumenau 4
Brooklyn 4
Chennai 4
Council Bluffs 4
Curitiba 4
Dhaka 4
Goiânia 4
Lima 4
Milan 4
Nanchang 4
Ottawa 4
Redwood City 4
Shenzhen 4
Vienna 4
Waverly Hall 4
Campinas 3
Catania 3
Florence 3
Guangzhou 3
Jakarta 3
Johannesburg 3
Manaus 3
Manchester 3
Mislata 3
Montreal 3
Nairobi 3
Oklahoma City 3
Olomouc 3
Phoenix 3
Pune 3
Salvador 3
San Francisco 3
Santa Domenica 3
Santo André 3
Shanghai 3
São Bernardo do Campo 3
Temple 3
Toronto 3
Torregrotta 3
Wroclaw 3
Totale 2.406
Nome #
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 200
PRRT Retreatments: Renal Function Evaluation 199
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 195
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 192
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 181
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 180
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 179
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 175
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 172
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 171
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 170
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 170
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 162
Renal Function Evaluation in PRRT Retreatments 156
PRRT retreatments: renal function evaluation 149
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 148
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 143
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 139
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 135
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 130
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 129
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 117
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 113
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 102
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 98
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 82
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 79
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 75
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 75
null 23
Totale 4.239
Categoria #
all - tutte 14.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 9 9
2021/2022228 1 13 2 10 20 1 21 21 2 25 20 92
2022/2023626 55 90 27 59 46 58 8 46 217 5 12 3
2023/2024146 13 13 7 8 18 22 9 10 0 13 13 20
2024/2025765 9 22 17 30 50 25 54 118 169 68 122 81
2025/20262.230 174 118 102 103 171 512 267 338 309 120 16 0
Totale 4.239